BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24913355)

  • 1. Expression and Y435-phosphorylation of Abelson interactor 1 (Abi1) promotes tumour cell adhesion, extracellular matrix degradation and invasion by colorectal carcinoma cells.
    Steinestel K; Brüderlein S; Lennerz JK; Steinestel J; Kraft K; Pröpper C; Meineke V; Möller P
    Mol Cancer; 2014 Jun; 13():145. PubMed ID: 24913355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abelson interactor 1 (Abi1) in colorectal cancer. From synaptic plasticity to tumor cell migration].
    Steinestel K; Gläsle F; Brüderlein S; Steinestel J; Pröpper C; Möller P
    Pathologe; 2013 Nov; 34 Suppl 2():189-94. PubMed ID: 24196611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis.
    Steinestel K; Brüderlein S; Steinestel J; Märkl B; Schwerer MJ; Arndt A; Kraft K; Pröpper C; Möller P
    PLoS One; 2012; 7(7):e40671. PubMed ID: 22808230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abelson interactor 1 splice isoform-L plays an anti-oncogenic role in colorectal carcinoma through interactions with WAVE2 and full-length Abelson interactor 1.
    Li K; Peng YF; Guo JZ; Li M; Zhang Y; Chen JY; Lin TR; Yu X; Yu WD
    World J Gastroenterol; 2021 Apr; 27(15):1595-1615. PubMed ID: 33958846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles and prognostic significance of ABI1-TSV-11 expression in patients with left-sided colorectal cancer.
    Zhang Y; Zhong Z; Li M; Chen J; Lin T; Sun J; Wang D; Mu Q; Su H; Wu N; Liu A; Yu Y; Zhang M; Liu Y; Guo J; Yu W
    Sci Rep; 2021 May; 11(1):10734. PubMed ID: 34031495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the adapter protein Abi1 in actin-associated signaling and smooth muscle contraction.
    Wang T; Cleary RA; Wang R; Tang DD
    J Biol Chem; 2013 Jul; 288(28):20713-22. PubMed ID: 23740246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive roles of Abi1 in regulating actin-associated proteins during human smooth muscle cell migration.
    Wang R; Liao G; Wang Y; Tang DD
    Sci Rep; 2020 Jun; 10(1):10667. PubMed ID: 32606387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo.
    Yu W; Sun X; Clough N; Cobos E; Tao Y; Dai Z
    Carcinogenesis; 2008 Sep; 29(9):1717-24. PubMed ID: 18453543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abelson tyrosine kinase facilitates Salmonella enterica serovar Typhimurium entry into epithelial cells.
    Ly KT; Casanova JE
    Infect Immun; 2009 Jan; 77(1):60-9. PubMed ID: 18936177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells.
    Sun X; Li C; Zhuang C; Gilmore WC; Cobos E; Tao Y; Dai Z
    Carcinogenesis; 2009 Dec; 30(12):2109-16. PubMed ID: 19843640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abl-interactor-1 (Abi1) has a role in cardiovascular and placental development and is a binding partner of the alpha4 integrin.
    Ring C; Ginsberg MH; Haling J; Pendergast AM
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):149-54. PubMed ID: 21173240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
    Wang JL; Yan TT; Long C; Cai WW
    Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulator proteins of actin dynamics as possible targets of antineoplastic therapies].
    Steinestel K
    Pathologe; 2018 Dec; 39(Suppl 2):225-230. PubMed ID: 30229281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.
    Wang C; Tran-Thanh D; Moreno JC; Cawthorn TR; Jacks LM; Wang DY; McCready DR; Done SJ
    Breast Cancer Res Treat; 2011 Sep; 129(2):373-86. PubMed ID: 21046228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.
    Kumar S; Lu B; Dixit U; Hossain S; Liu Y; Li J; Hornbeck P; Zheng W; Sowalsky AG; Kotula L; Birge RB
    Oncotarget; 2015 Nov; 6(35):37792-807. PubMed ID: 26473374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation of Abelson interactor 1 at K416 regulates actin cytoskeleton and smooth muscle contraction.
    Wang Y; Liao G; Wang R; Tang DD
    FASEB J; 2021 Sep; 35(9):e21811. PubMed ID: 34369620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK1-mediated phosphorylation of Abi1 attenuates Bcr-Abl-induced F-actin assembly and tyrosine phosphorylation of WAVE complex during mitosis.
    Zhuang C; Tang H; Dissanaike S; Cobos E; Tao Y; Dai Z
    J Biol Chem; 2011 Nov; 286(44):38614-38626. PubMed ID: 21900237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
    Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
    Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571.
    Bellone G; Ferrero D; Carbone A; De Quadros MR; Gramigni C; Prati A; Davidson W; Mioli P; Dughera L; Emanuelli G; Rodeck U
    Cancer Biol Ther; 2004 Apr; 3(4):385-92. PubMed ID: 14726674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.